|
US4299814A
(en)
|
1979-05-25 |
1981-11-10 |
Monsanto Company |
Radioimmunoassay of MIF
|
|
JPH0672158B2
(ja)
*
|
1984-05-24 |
1994-09-14 |
チバ−ガイギ− アクチエンゲゼルシヤフト |
精製されたヒトマクロファージ遊走阻止因子
|
|
US4946674A
(en)
|
1984-10-05 |
1990-08-07 |
Bioferon Biochemische Substanzen Gmbh & Co. |
Process for treatment of rheumatic diseases
|
|
US4708937A
(en)
|
1984-10-15 |
1987-11-24 |
Brigham & Women's Hospital |
Purified migration inhibitory factor also having colony stimulating factor activity
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
ES2052602T3
(es)
|
1986-10-03 |
1994-07-16 |
Ciba Geigy Ag |
Nuevos peptidos afines a las linfocinas.
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0463037A1
(en)
|
1989-03-17 |
1992-01-02 |
Genetics Institute, Inc. |
Human macrophage migration inhibitory factor
|
|
US5785054A
(en)
|
1989-06-06 |
1998-07-28 |
Kelly; Patrick D. |
Genital lubricant with zinc salt, labelled as anti-viral agent
|
|
GB8915414D0
(en)
|
1989-07-05 |
1989-08-23 |
Ciba Geigy |
Novel cytokines
|
|
CA2044590A1
(en)
|
1989-11-13 |
1991-05-14 |
Marc D. Better |
Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
|
|
US5227459A
(en)
|
1990-05-18 |
1993-07-13 |
Yale University |
Synthetic melanin
|
|
US5786168A
(en)
|
1990-06-04 |
1998-07-28 |
Kirin Beer Kabushiki Kaisha |
Method for recombinant production of antigen non-specific glycosylation inhibiting factor (GIF)
|
|
US5585479A
(en)
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
|
US6774227B1
(en)
|
1993-05-17 |
2004-08-10 |
Cytokine Pharmasciences, Inc. |
Therapeutic uses of factors which inhibit or neutralize MIF activity
|
|
DE69435303D1
(de)
|
1993-05-17 |
2010-09-02 |
Cytokine Pharmasciences Inc |
Er behandlung von krankheiten bei denen eine cytok
|
|
US6645493B1
(en)
|
1993-05-17 |
2003-11-11 |
The Picower Institute For Medical Research |
Composition containing anti-MIF antibody
|
|
US5559028A
(en)
|
1993-05-19 |
1996-09-24 |
Antigen Express, Inc. |
Methods of enhancing or antigen presentation to T cells inhibiting
|
|
EP0770086A4
(en)
|
1994-05-16 |
1998-07-15 |
Human Genome Sciences Inc |
MACROPHAGE MIGRATION INHIBITING FACTOR-3
|
|
US5747023A
(en)
|
1994-07-01 |
1998-05-05 |
Genentech, Inc. |
Cancer therapy using lymphotoxin
|
|
SI9400363A
(en)
|
1994-09-19 |
1996-08-31 |
Mozetic Francky Bojana |
Human macrophage migration inhibitory factor of nonlymphoid origin, expression of mif in e. coli and purification of recombinant protein
|
|
WO1996015242A2
(en)
|
1994-11-16 |
1996-05-23 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor
|
|
JPH0977799A
(ja)
|
1995-09-13 |
1997-03-25 |
Sapporo Immuno Diagnostic Lab:Kk |
ヒト−マクロファージ遊走阻止因子（ヒト−ｍｉｆ）に対するモノクローナル抗体および該抗体を産生するハイブリドーマ
|
|
AU1087797A
(en)
|
1996-01-03 |
1997-08-01 |
Australian National University, The |
Clip analogues and autoimmune disease
|
|
US6420188B1
(en)
|
1996-02-16 |
2002-07-16 |
The Picower Institute For Medical Research |
Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
|
|
US6492428B1
(en)
|
2000-07-26 |
2002-12-10 |
The Picower Institute For Medical Research |
Compounds having MIF antagonist activity
|
|
US5726020A
(en)
|
1996-06-11 |
1998-03-10 |
University Of Massachusetts |
Inhibition of II synthesis
|
|
US6297253B1
(en)
|
1996-10-15 |
2001-10-02 |
The Picower Institute For Medical Research |
Compounds and methods of use to treat infectious diseases
|
|
AU6336398A
(en)
|
1997-02-24 |
1998-09-09 |
Johns Hopkins University, The |
Immunomodulatory polypeptides derived from the invariant chain of mhc class ii
|
|
ES2248898T3
(es)
|
1997-05-02 |
2006-03-16 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Inmunotoxinas que comprenden una proteina onc dirigida contra celulas malignas.
|
|
CA2205680A1
(en)
|
1997-05-16 |
1998-11-16 |
The University Of Western Ontario |
Clip immunomodulatory peptide
|
|
US6011005A
(en)
|
1997-09-18 |
2000-01-04 |
The Picower Institute For Medical Research |
Prevention of pregnancy miscarriages
|
|
PT1028738E
(pt)
|
1997-11-05 |
2003-08-29 |
Univ Southern California |
Utilizacao de citoquinas e mitogenios para inibir respostas imunitarias patologicas
|
|
HU229520B1
(en)
|
1999-02-12 |
2014-01-28 |
Scripps Research Inst |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
|
|
WO2001032606A1
(en)
|
1999-10-29 |
2001-05-10 |
The Picower Institute For Medical Research |
Compounds having mif antagonist activity
|
|
US6268151B1
(en)
|
2000-01-20 |
2001-07-31 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of macrophage migration inhibitory factor expression
|
|
WO2001064749A2
(en)
*
|
2000-02-28 |
2001-09-07 |
Idec Pharmaceuticals Corporation |
Method for preparing anti-mif antibodies
|
|
WO2002079517A1
(en)
|
2001-03-29 |
2002-10-10 |
Cytokine Pharmasciences, Inc. |
Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
|
|
MY140679A
(en)
|
2001-05-24 |
2010-01-15 |
Avanir Pharmaceuticals |
Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
|
|
US7205107B2
(en)
|
2001-12-21 |
2007-04-17 |
Cytokine Pharmasciences, Inc. |
Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
|
|
US20050202010A1
(en)
|
2003-08-29 |
2005-09-15 |
Giroir Brett P. |
Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
|
|
US8883160B2
(en)
|
2004-02-13 |
2014-11-11 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
|
CN101374546B
(zh)
|
2005-12-16 |
2016-03-23 |
Ibc医药公司 |
基于免疫球蛋白的多价生物活性装配体
|
|
CN100457895C
(zh)
|
2006-05-24 |
2009-02-04 |
中国科学院生物物理研究所 |
鼠抗人巨噬细胞迁移抑制因子单克隆抗体及其应用
|
|
KR20160105943A
(ko)
|
2008-01-04 |
2016-09-07 |
백스터 인터내셔널 인코포레이티드 |
항 ｍｉｆ 항체
|
|
EP2079202A1
(en)
*
|
2008-01-08 |
2009-07-15 |
NEC Corporation |
Method for optimizing the triggering of the transmission of buffer status reporting (BSR) information
|
|
WO2011090492A1
(en)
|
2010-01-19 |
2011-07-28 |
Immunomedics, Inc. |
Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
|
|
WO2013050457A1
(en)
|
2011-10-07 |
2013-04-11 |
Baxter Healthcare S.A. |
Characterization of cho-mif gene and protein, and use thereof
|
|
JP2014530360A
(ja)
|
2011-10-07 |
2014-11-17 |
バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ |
診断マーカーとしてのｏｘＭＩＦ
|